FDA Inspection
Chongqing Daxin Pharmaceutical Co., Ltd.Chongqing Daxin Pharmaceutical Co., Ltd. – FDA Inspection, Apr 18, 2013
Record Details
This FDA Inspection record concerns Chongqing Daxin Pharmaceutical Co., Ltd., with an inspection on April 18, 2013, issued by the Center for Drug Evaluation and Research, covering drugs.
- Inspection Date
- April 18, 2013
- Product Type
- Drugs
View Company Profile
ID · 31798eea-e595-4356-9da9-977f526ea7a7
Inspection Facts
No Action Indicated (NAI)
No objectionable conditions or practices were found during the inspection.
- Inspection number
- 829548
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
Other FDA inspections of Chongqing Daxin Pharmaceutical Co., Ltd.
2| Date | Classification | Office | Project area |
|---|---|---|---|
| August 4, 2016 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| August 6, 2009 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Chongqing Daxin Pharmaceutical Co., Ltd.
- FDA Inspection 984549 - 2016-08-04
- FDA Inspection 616428 - 2009-08-06
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.